Maintenance of the dormant tumour within the equilibrium phase is reliant on adaptive immunity – and specifically CD8+ T cells – as opposed to innate cells such as NK cells (42) as the large majority of cancers in the equilibrium phase of immunoediting express MHC-1 (48). Here, CD8A is linked to cancer.